Cargando…
CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease
BACKGROUND AND OBJECTIVES: We assessed longitudinal changes in CSF microRNAs (miRNAs) in patients with moderately severe Parkinson disease. METHODS: We used next-generation whole-genome miRNA sequencing to determine CSF miRNA expression in 75 patients with Parkinson disease after single random ascen...
Autores principales: | Fowler, Alan J., Ahn, Jaeil, Hebron, Michaeline, Chiu, Timothy, Ayoub, Reem, Mulki, Sanjana, Ressom, Habtom, Torres-Yaghi, Yasar, Wilmarth, Barbara, Pagan, Fernando L., Moussa, Charbel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589263/ https://www.ncbi.nlm.nih.gov/pubmed/34786477 http://dx.doi.org/10.1212/NXG.0000000000000633 |
Ejemplares similares
-
Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
por: Pagan, Fernando L., et al.
Publicado: (2020) -
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies
por: Pagan, Fernando L., et al.
Publicado: (2022) -
4564 Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the cerebrospinal fluid of Parkinson’s patients
por: Fowler, Alan, et al.
Publicado: (2020) -
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial
por: Pagan, Fernando. L., et al.
Publicado: (2020) -
Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
por: Pagan, Fernando, et al.
Publicado: (2016)